• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis.

作者信息

Guy Alexandre, Danaee Anicee, Paschalaki Koralia, Boureau Lisa, Rivière Etienne, Etienne Gabriel, Mansier Olivier, Laffan Michael, Sekhar Mallika, James Chloe

机构信息

University of Bordeaux, UMR1034, Inserm, Biology of Cardiovascular Diseases, F-33600 Pessac, France.

CHU de Bordeaux, Laboratoire d'Hématologie, F-33600 Pessac, France.

出版信息

Hemasphere. 2020 May 5;4(3):e364. doi: 10.1097/HS9.0000000000000364. eCollection 2020 Jun.

DOI:10.1097/HS9.0000000000000364
PMID:32647794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7306304/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe85/7306304/238d8d949433/hs9-4-e364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe85/7306304/238d8d949433/hs9-4-e364-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe85/7306304/238d8d949433/hs9-4-e364-g002.jpg

相似文献

1
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis.伴有JAK2V617F骨髓增殖性肿瘤和内脏静脉血栓形成的患者中不存在JAK2V617F突变的内皮祖细胞
Hemasphere. 2020 May 5;4(3):e364. doi: 10.1097/HS9.0000000000000364. eCollection 2020 Jun.
2
Erythrocytes from patients with myeloproliferative neoplasms and splanchnic venous thrombosis show greater expression of Lu/BCAM.骨髓增殖性肿瘤合并脾静脉血栓形成患者的红细胞表达更高水平的 Lu/BCAM。
Int J Lab Hematol. 2018 Aug;40(4):473-477. doi: 10.1111/ijlh.12838. Epub 2018 May 13.
3
[Budd-Chiari syndrome and splanchnic vein thrombosis: masked myeloproliferative neoplasms and JAK2V617F].[布加综合征与内脏静脉血栓形成：隐匿性骨髓增殖性肿瘤与JAK2V617F]
Clin Ter. 2010;161(2):169-71.
4
JAK2V617F mutation screening as part of the hypercoagulable work-up in the absence of splanchnic venous thrombosis or overt myeloproliferative neoplasm: assessment of value in a series of 664 consecutive patients.在无内脏静脉血栓形成或明显骨髓增殖性肿瘤的情况下，JAK2V617F突变筛查作为高凝检查的一部分：对664例连续患者的价值评估
Mayo Clin Proc. 2008 Apr;83(4):457-9. doi: 10.4065/83.4.457.
5
Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease.下腔静脉血栓形成及其与 JAK2V617F 突变和慢性骨髓增殖性疾病的关系。
Thromb Res. 2012 Jun;129(6):720-4. doi: 10.1016/j.thromres.2011.09.011. Epub 2011 Oct 7.
6
Prevalence of CALR mutations in splanchnic vein thrombosis: A systematic review and meta-analysis.CALR 突变在肠系膜静脉血栓形成中的流行情况：系统评价和荟萃分析。
Thromb Res. 2018 Jul;167:96-103. doi: 10.1016/j.thromres.2018.05.007. Epub 2018 May 8.
7
[Splanchnic vein thrombosis as a first manifestation of Primary myelofibrosis].[内脏静脉血栓形成作为原发性骨髓纤维化的首发表现]
Gac Med Mex. 2017;153(4):537-540. doi: 10.24875/GMM.17002822.
8
JAK2V617F mutation and myeloproliferative disorders in splanchnic vein thrombosis.内脏静脉血栓形成中的JAK2V617F突变与骨髓增殖性疾病
Aliment Pharmacol Ther. 2011 Feb;33(4):495-6; author reply 496-7. doi: 10.1111/j.1365-2036.2010.04533.x.
9
Thrombosis in myeloproliferative neoplasms with JAK2V617F mutation.JAK2V617F 突变的骨髓增殖性肿瘤中的血栓形成。
Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):374-81. doi: 10.1177/1076029612453761. Epub 2012 Jul 23.
10
Prevalence of JAK2V617F mutation in deep venous thrombosis patients and its clinical significance as a thrombophilic risk factor: Indian perspective.JAK2V617F突变在深静脉血栓形成患者中的患病率及其作为血栓形成风险因素的临床意义：印度视角
Clin Appl Thromb Hemost. 2015 Sep;21(6):579-83. doi: 10.1177/1076029615578166. Epub 2015 Mar 23.

引用本文的文献

1
Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis.JAK2V617F 等位基因负担与真性红细胞增多症临床相关性的系统评价和荟萃分析。
Ann Hematol. 2024 Jun;103(6):1947-1965. doi: 10.1007/s00277-024-05754-4. Epub 2024 Apr 23.
2
Exploring the Molecular Aspects of Myeloproliferative Neoplasms Associated with Unusual Site Vein Thrombosis: Review of the Literature and Latest Insights.探讨与异常部位静脉血栓形成相关的骨髓增殖性肿瘤的分子方面：文献回顾与最新见解。
Int J Mol Sci. 2024 Jan 26;25(3):1524. doi: 10.3390/ijms25031524.
3
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte-endothelial proadhesive interactions.

本文引用的文献

1
Recent Advances in Endothelial Colony Forming Cells Toward Their Use in Clinical Translation.内皮祖细胞在临床转化应用方面的最新进展
Front Med (Lausanne). 2018 Oct 23;5:295. doi: 10.3389/fmed.2018.00295. eCollection 2018.
2
Vascular endothelial cell expression of JAK2 is sufficient to promote a pro-thrombotic state due to increased P-selectin expression.血管内皮细胞 JAK2 的表达足以通过增加 P-选择素的表达来促进促血栓形成状态。
Haematologica. 2019 Jan;104(1):70-81. doi: 10.3324/haematol.2018.195321. Epub 2018 Aug 31.
3
Endothelial Progenitors: A Consensus Statement on Nomenclature.
JAK-STAT 抑制可减少内皮细胞促血栓形成激活和白细胞-内皮细胞的促黏附相互作用。
J Thromb Haemost. 2023 May;21(5):1366-1380. doi: 10.1016/j.jtha.2023.01.027. Epub 2023 Feb 2.
4
Splanchnic Vein Thrombosis in Myeloproliferative Neoplasms: Treatment Considerations and Unmet Needs.骨髓增殖性肿瘤中的内脏静脉血栓形成：治疗考量与未满足的需求
Cancers (Basel). 2022 Dec 20;15(1):11. doi: 10.3390/cancers15010011.
5
Comparative Mutational Profiling of Hematopoietic Progenitor Cells and Circulating Endothelial Cells (CECs) in Patients with Primary Myelofibrosis.原发性骨髓纤维化患者造血祖细胞与循环内皮细胞的比较突变分析。
Cells. 2021 Oct 15;10(10):2764. doi: 10.3390/cells10102764.
6
The possible role of mutated endothelial cells in myeloproliferative neoplasms.突变内皮细胞在骨髓增殖性肿瘤中的可能作用。
Haematologica. 2021 Nov 1;106(11):2813-2823. doi: 10.3324/haematol.2021.278499.
7
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms.BCR-ABL1 阴性骨髓增殖性肿瘤中心血管事件的发病机制。
Leukemia. 2021 Apr;35(4):935-955. doi: 10.1038/s41375-021-01170-z. Epub 2021 Mar 3.
8
Role of Inflammatory Factors during Disease Pathogenesis and Stem Cell Transplantation in Myeloproliferative Neoplasms.炎症因子在骨髓增殖性肿瘤疾病发病机制及干细胞移植中的作用
Cancers (Basel). 2020 Aug 12;12(8):2250. doi: 10.3390/cancers12082250.
内皮祖细胞：命名共识声明。
Stem Cells Transl Med. 2017 May;6(5):1316-1320. doi: 10.1002/sctm.16-0360. Epub 2017 Mar 10.
4
Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm.JAK2V617F阳性且无骨髓增殖性肿瘤的布加综合征患者的粒细胞全外显子组测序及内皮JAK2V617F研究
Br J Haematol. 2018 Feb;180(3):443-445. doi: 10.1111/bjh.14327. Epub 2016 Sep 21.
5
Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence.吸烟者和慢性阻塞性肺疾病患者的内皮祖细胞功能障碍，原因是DNA损伤和衰老增加。
Stem Cells. 2013 Dec;31(12):2813-26. doi: 10.1002/stem.1488.
6
Splanchnic vein thrombosis in myeloproliferative neoplasms.骨髓增殖性肿瘤中的内脏静脉血栓形成。
Br J Haematol. 2013 Sep;162(6):730-47. doi: 10.1111/bjh.12461. Epub 2013 Jul 15.
7
Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.骨髓纤维化患者的脾脏内皮细胞存在 JAK2V617F 突变。
Blood. 2013 Jan 10;121(2):360-8. doi: 10.1182/blood-2012-01-404889. Epub 2012 Nov 5.
8
Endothelial progenitor cells are clonal and exhibit the JAK2(V617F) mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms.内皮祖细胞是克隆性的，在一部分 Ph 阴性骨髓增生性肿瘤伴血栓形成的患者中存在 JAK2(V617F)突变。
Blood. 2011 Mar 3;117(9):2700-7. doi: 10.1182/blood-2010-07-297598. Epub 2011 Jan 6.
9
Endothelial von Willebrand factor regulates angiogenesis.内皮型血管性血友病因子调节血管生成。
Blood. 2011 Jan 20;117(3):1071-80. doi: 10.1182/blood-2010-01-264507. Epub 2010 Nov 3.
10
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker.慢性骨髓增殖性疾病患者的内皮祖细胞缺乏疾病特异性分子克隆性标志物。
Blood. 2009 Oct 1;114(14):3127-30. doi: 10.1182/blood-2008-12-190991. Epub 2009 Jul 23.